Search
for
Sort by
Research 601–630 of 1000+
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Clascoterone: First Approval
- Genetic and molecular aspects of androgenetic alopecia
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
- Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Adolescent acne: association to sex, puberty, testosterone and dihydrotestosterone
- A Scientific Hypothesis on the Role of Nutritional Supplements for Effective Management of Hair Loss and Promoting Hair Regrowth
- Dutasteride nanoemulsion preparation to inhibit 5-alpha-hair follicle reductase enzymes in the hair follicle; an ex vivo study.
- Acne-Associated Syndromes
- Comparison of Alopecia severity and blood level of testosterone in men suffering schizophrenia with control group
- 5α-Reductase underscores the development of pectoral fin breeding tubercles in zebrafish
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
- Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia
- Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review
- Biomedical applications of electrospun nanofibers in the management of androgenic alopecia
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Testosterone’s regulation of the HPA axis differs for adolescent and adult male rats
- Co-editors’ Messages
- Hair loss in women
- Use of oral contraceptives in the management of acne
- Hair Sciences: The hair cycle discussed with Dr. Gilliam Westgate
- Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A
- Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A
- Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A
- Biomaterials for Treatment of Baldness
- The evaluation and management of hirsutism*1